Interim estimates of vaccine effectiveness of Pfizer-BioNTech and Moderna COVID-19 vaccines among health care personnel—33 US sites, January–March 2021 T Pilishvili MMWR. Morbidity and mortality weekly report 70, 2021 | 231 | 2021 |
Effects of smoking on non-AIDS-related morbidity in HIV-infected patients DK Shirley, RJ Kaner, MJ Glesby Clinical infectious diseases 57 (2), 275-282, 2013 | 95 | 2013 |
Prevalence, risk factors, and outcomes of idle intravenous catheters: an integrative review MB Becerra, D Shirley, N Safdar American journal of infection control 44 (10), e167-e172, 2016 | 70 | 2016 |
Factors associated with smoking in HIV-infected patients and potential barriers to cessation DK Shirley, RK Kesari, MJ Glesby AIDS patient care and STDs 27 (11), 604-612, 2013 | 56 | 2013 |
Prevalence of antimicrobial resistance and its clinical implications in Ethiopia: a systematic review DF Berhe, GT Beyene, B Seyoum, M Gebre, K Haile, M Tsegaye, ... Antimicrobial Resistance & Infection Control 10, 1-14, 2021 | 48 | 2021 |
Wisconsin microbiome study, a cross-sectional investigation of dietary fibre, microbiome composition and antibiotic-resistant organisms: rationale and methods S Eggers, KMC Malecki, P Peppard, J Mares, D Shirley, SK Shukla, ... BMJ open 8 (3), e019450, 2018 | 40 | 2018 |
Risk factors for infection with multidrug-resistant organisms in Haryana, India S Kalluru, S Eggers, A Barker, D Shirley, AK Sethi, S Sengupta, K Yeptho, ... American journal of infection control 46 (3), 341-345, 2018 | 29 | 2018 |
Screening for chronic obstructive pulmonary disease (COPD) in an urban HIV clinic: a pilot study DK Shirley, RJ Kaner, MJ Glesby AIDS patient care and STDs 29 (5), 232-239, 2015 | 29 | 2015 |
Outcomes of Community and Healthcare-onset Clostridium difficile Infections MC Mora Pinzon, R Buie, J Liou, DK Shirley, CT Evans, S Ramanathan, ... Clinical Infectious Diseases 68 (8), 1343-1350, 2019 | 22 | 2019 |
Optimizing inpatient urine culture ordering practices using the electronic medical record: a pilot study D Shirley, H Scholtz, K Osterby, J Musuuza, B Fox, N Safdar infection control & hospital epidemiology 38 (4), 486-488, 2017 | 16 | 2017 |
Cessation-related information, motivation, and behavioral skills in smokers living with HIV D Shirley, L Thibodeau, SL Catz, K McCoy, DE Jorenby, N Safdar, ... AIDS care 30 (2), 131-139, 2018 | 15 | 2018 |
Neighborhood disadvantage and 30-day readmission risk following Clostridioides difficile infection hospitalization E Scaria, WR Powell, J Birstler, O Alagoz, D Shirley, AJH Kind, N Safdar BMC infectious diseases 20, 1-10, 2020 | 14 | 2020 |
Incorporation of leadership rounds in CAUTI prevention efforts S Purvis, GD Kennedy, MJ Knobloch, A Marver, J Marx, S Rees, N Safdar, ... Journal of Nursing Care Quality 32 (4), 318-323, 2017 | 14 | 2017 |
Teaching health care workers to adopt a systems perspective for improved control and prevention of health care–associated infections AR Ruis, DW Shaffer, DK Shirley, N Safdar American journal of infection control 44 (11), 1360-1364, 2016 | 12 | 2016 |
External Validation and Comparison of Clostridioides difficile Severity Scoring Systems DA Perry, D Shirley, D Micic, PC Patel, R Putler, A Menon, VB Young, ... Clinical Infectious Diseases 74 (11), 2028-2035, 2022 | 11 | 2022 |
Implementation of infection control measures to prevent healthcare-associated transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) AJ Lepak, DK Shirley, A Buys, L Stevens, N Safdar Infection Control & Hospital Epidemiology 42 (2), 229-232, 2021 | 11 | 2021 |
Development of a pharmacist-led opt-out cessation treatment protocol for combustible tobacco smoking within inpatient settings PJ Trapskin, A Sheehy, PD Creswell, DE McCarthy, A Skora, RT Adsit, ... Hospital Pharmacy 57 (1), 167-175, 2022 | 10 | 2022 |
Utilizing the SEIPS model to guide hand hygiene interventions at a tertiary hospital in Ethiopia L Berman, M Kavalier, B Gelana, G Tesfaw, D Siraj, D Shirley, D Yilma PloS one 16 (10), e0258662, 2021 | 10 | 2021 |
Risk factors and mortality for atypical presentation of COVID-19 infection in hospitalized patients-lessons from the early pandemic A Pop-Vicas, A Haleem, F Osman, R Fuglestad, D Shirley, R Striker, ... Wmj 120 (2), 94-99, 2021 | 9 | 2021 |
Barriers and facilitators to injection safety in ambulatory care settings C Leback, DH Johnson, L Anderson, K Rogers, D Shirley, N Safdar infection control & hospital epidemiology 39 (7), 841-848, 2018 | 9 | 2018 |